Macrovascular disease in the elderly with type 1 diabetes

Mark Chapman; Parth Narendran; Mark Anderson; Krishnarajah Nirantharakumar; T.E Purvis; P. L Whittaker; R Bhattacharjee; P Marshall

doi:10.4172/2155-6156.1000299

Macrovascular disease in the elderly with type 1 diabetes

Mark Chapman, Parth Narendran, Mark Anderson, Krishnarajah Nirantharakumar, T.E Purvis, P. L Whittaker, R Bhattacharjee, P Marshall

Research output: Contribution to journal › Article › peer-review

Abstract

Macrovascular disease (MVD) is a major complication of type 1 diabetes mellitus. However, accurate data on the prevalence and impact of macrovascular disease in the elderly with type 1 diabetes is lacking. This is despite life expectancy increasing in this population. Using data from over 400 general practices in the UK, the prevalence of macrovascular disease and factors associated with it were identified in elderly (over 65years) patients with type 1 diabetes for the year 2008.In this population, there was high prevalence of macrovascular disease(39.5%). Patients with macrovascular disease were significantly older, had a longer duration of diabetes, a positive history of smoking and higher HbA1cvalues. Our analysis demonstrates a high burden of macrovascular disease in elderly patients with type 1 diabetes. We need to explore how best to address this disease in this population.

Original language	English
Article number	8
Journal	Journal of Diabetes and Metabolism
Volume	4
DOIs	https://doi.org/10.4172/2155-6156.1000299
Publication status	Published - 30 Sept 2013

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.4172/2155-6156.1000299Licence: Creative Commons: Attribution (CC BY)

Cite this

@article{efda4fc70caf4df4be7bb2ec97c8c083,

title = "Macrovascular disease in the elderly with type 1 diabetes",

abstract = "Macrovascular disease (MVD) is a major complication of type 1 diabetes mellitus. However, accurate data on the prevalence and impact of macrovascular disease in the elderly with type 1 diabetes is lacking. This is despite life expectancy increasing in this population. Using data from over 400 general practices in the UK, the prevalence of macrovascular disease and factors associated with it were identified in elderly (over 65years) patients with type 1 diabetes for the year 2008.In this population, there was high prevalence of macrovascular disease(39.5%). Patients with macrovascular disease were significantly older, had a longer duration of diabetes, a positive history of smoking and higher HbA1cvalues. Our analysis demonstrates a high burden of macrovascular disease in elderly patients with type 1 diabetes. We need to explore how best to address this disease in this population.",

author = "Mark Chapman and Parth Narendran and Mark Anderson and Krishnarajah Nirantharakumar and T.E Purvis and Whittaker, {P. L} and R Bhattacharjee and P Marshall",

year = "2013",

month = sep,

day = "30",

doi = "10.4172/2155-6156.1000299",

language = "English",

volume = "4",

journal = "Journal of Diabetes and Metabolism",

publisher = "OMICS International",

}

TY - JOUR

T1 - Macrovascular disease in the elderly with type 1 diabetes

AU - Chapman, Mark

AU - Narendran, Parth

AU - Anderson, Mark

AU - Nirantharakumar, Krishnarajah

AU - Purvis, T.E

AU - Whittaker, P. L

AU - Bhattacharjee, R

AU - Marshall, P

PY - 2013/9/30

Y1 - 2013/9/30

N2 - Macrovascular disease (MVD) is a major complication of type 1 diabetes mellitus. However, accurate data on the prevalence and impact of macrovascular disease in the elderly with type 1 diabetes is lacking. This is despite life expectancy increasing in this population. Using data from over 400 general practices in the UK, the prevalence of macrovascular disease and factors associated with it were identified in elderly (over 65years) patients with type 1 diabetes for the year 2008.In this population, there was high prevalence of macrovascular disease(39.5%). Patients with macrovascular disease were significantly older, had a longer duration of diabetes, a positive history of smoking and higher HbA1cvalues. Our analysis demonstrates a high burden of macrovascular disease in elderly patients with type 1 diabetes. We need to explore how best to address this disease in this population.

AB - Macrovascular disease (MVD) is a major complication of type 1 diabetes mellitus. However, accurate data on the prevalence and impact of macrovascular disease in the elderly with type 1 diabetes is lacking. This is despite life expectancy increasing in this population. Using data from over 400 general practices in the UK, the prevalence of macrovascular disease and factors associated with it were identified in elderly (over 65years) patients with type 1 diabetes for the year 2008.In this population, there was high prevalence of macrovascular disease(39.5%). Patients with macrovascular disease were significantly older, had a longer duration of diabetes, a positive history of smoking and higher HbA1cvalues. Our analysis demonstrates a high burden of macrovascular disease in elderly patients with type 1 diabetes. We need to explore how best to address this disease in this population.

U2 - 10.4172/2155-6156.1000299

DO - 10.4172/2155-6156.1000299

M3 - Article

VL - 4

JO - Journal of Diabetes and Metabolism

JF - Journal of Diabetes and Metabolism

M1 - 8

ER -

Macrovascular disease in the elderly with type 1 diabetes

Abstract

UN SDGs

Access to Document

Fingerprint

Cite this